波多野结衣办公室双飞_制服 丝袜 综合 日韩 欧美_网站永久看片免费_欧美一级片在线免费观看_免费视频91蜜桃_精产国品一区二区三区_97超碰免费在线观看_欧美做受喷浆在线观看_国产熟妇搡bbbb搡bbbb_麻豆精品国产传媒

Global EditionASIA 中文雙語Fran?ais
Opinion
Home / Opinion / Featured Contributors

How moneyed interests spawned and sustained US opioid crisis

By Xu Ying | chinadaily.com.cn | Updated: 2023-10-16 10:31
Share
Share - WeChat
Cai Meng | China Daily

The opioid epidemic ravaging communities across America represents a profound public health crisis and moral failing decades in the making. This unfolding tragedy spotlights how profit motives and regulatory lapses incubated a contagion of addiction that enriched drug makers while extracting a ghastly human toll. Behind the statistics lie broken lives and betrayed trust.

The sheer scale of opioid mortality remains shocking despite growing awareness and mitigation efforts. With over 100,000 deaths in 2021 alone, opioid overdoses claimed more American lives yearly than car crashes or gun violence. And the crisis is worsening, with synthetic opioids like fentanyl causing record spikes in fatalities by permeating illicit drug supplies. This exponential loss of life now exceeds the darkest years of the AIDS epidemic.

Rather than a public health disaster happening organically, the opioid crisis was manufactured through calculated choices to drive addiction for profit. The relentless promotion of OxyContin as a low-risk analgesic directly seeded today's landscape littered with fatalities. Despite knowing the enormous dependency risks, the Sackler family deployed false marketing to push their blockbuster pill, raking in over $35 billion from Oxy sales since the 1990s.

The medical establishment shares culpability for becoming complicit conduits enabling mass over-prescription. Professional associations funded by opioid makers popularized the myth that doctors were under-treating chronic pain, abandoning caution about addictive risks. Misleading assertions that dependency was rare if opioids were properly prescribed for pain became common, despite contrary evidence. With incentives skewed, restraint was abandoned as doctors followed loosened guidelines.

Lax oversight from captured regulators like the FDA and DEA also facilitated the pharmaceutical free-for-all. Despite clear warnings about addiction and diversion, agencies succumbed to fierce industry lobbying to permit aggressive opioid marketing and distribution. Their regulatory surrender allowed and even abetted the ensuing epidemic rather than blocking it. This abdication of duty left Americans unprotected.

With profit seeking unconstrained and oversight neutered, conditions ripened for catastrophe on a national scale. The result after two decades was a historic public health crisis claiming over one million American lives, exceeding Vietnam War casualties. This colossal policy failure has rightly been labelled a "national disgrace" by reform advocates across the political spectrum.

Revelations of calculated choices sparking this crisis spotlight the corrosive influence of moneyed interests on governing institutions. The opioid epidemic illustrates how profit motives can capture regulators and corrupt policy to enrich a privileged few at monstrous public expense. The outsized lobbying power of opioid makers won them effective impunity while stifling reforms, allowing intended consequences to unfold.

Industry players secured enablers at the highest levels through strategic donations to politicians, advocacy groups, and regulators seeking influence. Opiate makers like Purdue lavished millions on contributions and lobbying funds to shape policy responses amenable to their bottom lines. Many lawmakers pursuing opioid deregulation were themselves among the biggest recipients of pharma cash, raising conflict of interest questions.

The notorious "revolving door" between regulators and regulated further entwined public agencies with opioid corporate interests. Several senior DEA officials involved in drug policy oversight have since joined opioid makers they once regulated, or defend them as lobbyists.

Such relationships inevitably raise doubts over whose interests the governing institutions truly serve under the capture of moneyed influences. Does the inordinate access and power of corporate lobbies undermine regulatory missions by corrupting public servants into servants of industry? Have democratic ideals of responsive leadership devolved into a system rigged by elite influence networks and tycoons? The tragic arc of the opioid crisis lends credence to critiques of America as a plutocracy masquerading as a republic.

As the opioid catastrophe escalated, responses from political leaders long paid to ignore warning signs ranged from tepid to complicit. Despite constituencies being decimated, many avoided policies that could curb profits, like prosecuting company leaders or funding treatment. Belated emergency decrees provided cover while avoiding real accountability. Opioid makers still reap billions in profits after paying settlements trivial relative to the scale of harms inflicted.

This sordid history raises skepticism about entrusting crisis response solely to the perpetrators and enablers who incubated the epidemic. Their pledges to make amends now ring hollow absent owning responsibility. Meaningful reforms appear necessary to constrain corporate power and corrupt elite influence that subordinate public welfare to private interests. Americans shaken by this nightmarish episode may conclude the institutions are too compromised to self-correct and must be redeemed through progress over plutocracy.

The merciless human toll of America's opioid plague spotlights endemic corruption of governing systems by moneyed special interests. This ongoing public health disaster was spawned by the callous pursuit of profit, enabled by regulatory surrender in the face of lobbying might. The scheme engorged the coffers of opioid makers while crushing families, communities, and faith in leaders. Its immense costs lay bare the moral bankruptcy of institutions serving the privileged few at such grievous public expense.

Redeeming civic promise requires truth, justice and change. The powerful must be held to account, balance restored to governance, and public interest reinstalled over private enrichment. For generations, the opioid crisis will be remembered as either the nadir spurring renewal, or another chapter of eroding trust as elites escape consequences. Its lessons must shape the necessary reckoning ahead to reclaim democracy from moneyed interests and reaffirm that all lives matter over lobbyists. In such a colossal crisis and tragedy, any attempt to shift blame onto others is an unforgivable crime of deceiving the American people.

The author is a Beijing-based commentator. The views don't necessarily reflect those of China Daily.

If you have a specific expertise, or would like to share your thought about our stories, then send us your writings at opinion@chinadaily.com.cn or comment@chinadaily.com.cn.

 

Most Viewed in 24 Hours
Top
BACK TO THE TOP
English
Copyright 1995 - . All rights reserved. The content (including but not limited to text, photo, multimedia information, etc) published in this site belongs to China Daily Information Co (CDIC). Without written authorization from CDIC, such content shall not be republished or used in any form. Note: Browsers with 1024*768 or higher resolution are suggested for this site.
License for publishing multimedia online 0108263

Registration Number: 130349
FOLLOW US
波多野结衣办公室双飞_制服 丝袜 综合 日韩 欧美_网站永久看片免费_欧美一级片在线免费观看_免费视频91蜜桃_精产国品一区二区三区_97超碰免费在线观看_欧美做受喷浆在线观看_国产熟妇搡bbbb搡bbbb_麻豆精品国产传媒
婷婷五月精品中文字幕| 日韩欧美国产精品| 中文字幕精品一区二区三区精品 | 亚洲国产精品一区二区久久hs| 精品日韩在线观看| 欧美aaaaa成人免费观看视频| 秘密基地免费观看完整版中文| 精品视频一区三区九区| 亚洲一区二区欧美日韩| 免费国偷自产拍精品视频| 在线观看网站黄不卡| 亚洲精品免费看| 中文字幕在线播放一区二区| 欧美日韩一区小说| 亚洲国产视频直播| 国产又黄又嫩又滑又白| 欧美精品一二三| 日本在线不卡一区| 色无极影院亚洲| 久久嫩草精品久久久久| 国产精品一区二区无线| 最新一区二区三区| 亚洲欧洲制服丝袜| 久久久久久久久久久久国产精品| 欧美日韩在线一区二区| 天堂在线亚洲视频| 国产中年熟女高潮大集合| 国产亚洲一区字幕| 成人性生交大片免费看视频在线 | 国产亚洲精品久久久久久豆腐| 中文字幕精品综合| 91首页免费视频| 91精品国产综合久久小美女| 男人的j进女人的j一区| 免费看91的网站| 中文字幕一区二区三| 极品人妻一区二区| 日韩美女一区二区三区四区| 国产精品一级片在线观看| 五月婷婷一区二区三区| 亚洲福利电影网| 久久亚洲无码视频| 国产精品久久久久三级| 日本少妇xxxx软件| 精品成人佐山爱一区二区| 懂色av一区二区三区免费观看| 欧美在线短视频| 美腿丝袜亚洲一区| 色综合一区二区| 三级欧美韩日大片在线看| avhd101老司机| 亚洲美女视频在线| 熟女俱乐部一区二区视频在线| 欧美国产在线观看| 中文字幕99页| 国产亚洲一本大道中文在线| 91免费视频观看| 精品国产伦一区二区三区观看方式| 国产成人啪午夜精品网站男同| 欧美日韩视频在线观看一区二区三区| 蜜桃av一区二区三区| 亚洲欧美一区二区三区四区五区| 视频一区二区国产| 午夜av入18在线| 麻豆一区二区99久久久久| 69av.com| 精品一区二区三区香蕉蜜桃| 色狠狠色狠狠综合| 久88久久88久久久| 欧美日韩国产中文| 国产成人免费视频网站高清观看视频 | 不许穿内裤随时挨c调教h苏绵| 久久久午夜电影| 精品人妻二区中文字幕| 国产欧美一区二区在线| 欧美肉大捧一进一出免费视频| 国产精品女同互慰在线看| 亚洲天堂美女视频| 亚洲精品午夜久久久| 在线观看免费小视频| 亚洲成av人片一区二区梦乃| 天天鲁一鲁摸一摸爽一爽| 日本系列欧美系列| 欧美午夜影院一区| 国产91对白在线观看九色| 日韩欧美不卡一区| 又色又爽又黄18网站| 国产精品久久久久aaaa樱花| b站大片免费直播| 亚洲成人免费视| 色欧美日韩亚洲| 国产精品夜夜嗨| 精品久久久久久无| 妖精视频一区二区| 怡红院av一区二区三区| 日韩国产第一页| 韩国三级电影一区二区| 91精品国产综合久久蜜臀| 91性感美女视频| 国产精品久久久久影院老司| 亚洲а∨天堂久久精品2021| 日韩国产在线观看一区| 欧美揉bbbbb揉bbbbb| av在线播放一区二区三区| 国产日本欧洲亚洲| 91精品国自产在线| 蜜臀久久久99精品久久久久久| 欧美日韩免费视频| 91视频免费播放| ●精品国产综合乱码久久久久| 又嫩又硬又黄又爽的视频| 精品一区二区三区免费毛片爱| 欧美一区在线视频| 日本精品一二三区| 亚洲一区精品在线| 欧美性大战久久久久久久蜜臀| gogogo免费视频观看亚洲一| 中文字幕一区av| av激情在线观看| 国产不卡高清在线观看视频| 国产欧美综合色| 在线日韩国产网站| 成人中文字幕在线| 国产精品剧情在线亚洲| 成人免费视频国产免费观看| 国产成人亚洲综合a∨婷婷| 亚洲国产成人在线| 黑鬼狂亚洲人videos| 国产高清不卡一区二区| 中文字幕不卡在线| 伊人在线视频观看| 99久久久无码国产精品| 亚洲免费毛片网站| 精品视频色一区| 中文字幕乱视频| 日日骚欧美日韩| 精品久久一二三区| 国产又黄又粗的视频| 国产成人自拍网| 欧美激情在线看| 日韩一级片av| 中文字幕永久免费| 午夜婷婷国产麻豆精品| 日韩精品一区二区三区蜜臀| 五月天精品视频| 成人精品高清在线| 亚洲综合色视频| 日韩一区二区视频在线观看| 亚洲成人网在线播放| 国产美女久久久久| 国产精品久久夜| 欧美亚洲一区二区在线| 在线免费观看污视频| 久久99精品久久只有精品| 欧美极品少妇xxxxⅹ高跟鞋| 一本一道波多野结衣一区二区 | 丁香婷婷综合网| 亚洲欧美日韩国产另类专区| 欧美老女人在线| japanese中文字幕| 国产91精品精华液一区二区三区| 亚洲三级视频在线观看| 欧美福利视频导航| 美国黑人一级大黄| 成人免费高清在线| 亚洲bt欧美bt精品777| 久久综合色之久久综合| 艳母动漫在线看| 久久午夜夜伦鲁鲁片| 国产精品一区免费视频| 亚洲精品老司机| 精品国产亚洲一区二区三区在线观看| 熟女av一区二区| 手机免费看av片| 国产精品91一区二区| 亚洲无人区一区| 久久精品视频免费| 欧美视频精品在线观看| 国产精品一二三区在线观看| eeuss鲁一区二区三区| 日韩精品91亚洲二区在线观看| 国产视频视频一区| 欧美日韩极品在线观看一区| 超碰人人干人人| 日本少妇一区二区三区| 韩日欧美一区二区三区| 亚洲欧美福利一区二区| 2024国产精品| 欧美吞精做爰啪啪高潮| 亚洲激情图片网| 婷婷五月精品中文字幕| 337p日本欧洲亚洲大胆张筱雨 | 成人国产视频在线观看| 日韩精品乱码免费| 亚洲视频一区二区在线| 精品久久久久久久一区二区蜜臀| 在线一区二区三区| 青青草自拍偷拍| 亚洲精品乱码久久| 99精品国产99久久久久久白柏|